FLXN

Q: What is the price of Flexion Therapeutics (FLXN) today?

The price of Flexion Therapeutics (FLXN) today is R$ 137,00, with a variation of 0% compared to the last year. The price of Flexion Therapeutics (FLXN) started the year trading around R$ 0,00 and today it is at R$ 137,00. Follow the real-time price chart, the historical price of Flexion Therapeutics (FLXN), and stock data from Ibovespa and international markets.

Q: When does Flexion Therapeutics (FLXN) pay dividends?

Flexion Therapeutics (FLXN) did not distribute dividends in the last year.

Q: Flexion Therapeutics (FLXN) is it worth it?

Currently, Flexion Therapeutics (FLXN) is priced at R$ 137,00, with a P/E of -12,47%, representing a deviation of -12,47% from its historical average P/E. In the last year, the stock showed a variation of 0% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,57%. The total shareholder return was 0,00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Flexion Therapeutics (FLXN)?

Investing in stocks of Flexion Therapeutics (FLXN) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Flexion Therapeutics (FLXN) yield today?

The yield of Flexion Therapeutics (FLXN) was 1,70% in the last month, 0,00% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,78 in dividends, um Dividend Yield de 0,57%.If you wanted to buy 100 stocks of Flexion Therapeutics (FLXN) today, the total investment would be R$ 13.700,11, based on the current price of R$ 137,00.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 13.700,11In 5 years: R$ 13.700,11In 10 years: 13.700,11It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Flexion Therapeutics Inc.

Price

US$ 25,56

variation (12m)

0,00%

p/l

-12,47

p/vp

-15,24

DIVIDEND YIELD

0,57%

price FLXN

BVMF

FLXN

If you had invested

years ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of FLXN

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

1,70%

3 months

0,00%

1 year

0,00%

2 years

0,00%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

1,70%

3 months

0,00%

1 year

0,00%

2 years

0,00%

5 years

0,00%

10 years

0,00%

Indicators FLXN

check out the fundamentals of Flexion Therapeutics shares

P/E

-12,47

Sector: -3,15 Industry: -3,15

P/SALES RATIO (PSR)

12,51

Sector: -4,36 Industry: -4,36

P/BV

-15,24

Sector: 1,77 Industry: 1,77

DIVIDEND YIELD (DY)

0,57%

Sector: - Industry: -

ROA

-46,22%

Sector: -63,23% Industry: -63,23%

ROE

122,27%

Sector: -69,95% Industry: -69,95%

ROIC

Sector: -2.093,52% Industry: -2.093,52%

NET MARGIN

-100,00%

Sector: -41,50% Industry: -41,50%

GROSS MARGIN

78,93%

Sector: 38,30% Industry: 38,30%

OPERATING MARGIN

-78,17%

Sector: -40,80% Industry: -40,80%

P/EBITDA

-15,82

Sector: -3,30 Industry: -3,30

P/EBIT

-14,69

Sector: -3,30 Industry: -3,30

P/ASSET

5,76

Sector: 1,31 Industry: 1,31

BVPS

-1,67

Sector: 1,82 Industry: 1,82

EPS

-2,04

Sector: -2,18 Industry: -2,18

EQUITY / ASSETS

-0,38

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

3,25%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

-2,40%

Sector: - Industry: -

FLXN indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	16,71	5,43	32,50%	2,83%	US$ 426,17 B	27,75%
PFE	15,38	1,59	10,33%	6,87%	US$ 141,44 B	15,13%
ABBV	100,08	-2.728,87	-2.726,81%	3,04%	US$ 376,58 B	6,45%
NVO	15,01	9,45	62,99%	3,05%	US$ 245,59 B	34,74%
MRK	11,91	4,29	36,03%	3,81%	US$ 210,57 B	28,16%
AZN	27,19	5,65	20,79%	2,53%	US$ 253,27 B	16,23%
BMY	18,63	5,49	29,44%	5,22%	US$ 95,93 B	10,71%
GILD	20,41	7,31	35,82%	2,71%	US$ 143,24 B	24,71%
ZTS	25,77	13,71	53,20%	1,26%	US$ 68,23 B	28,00%
HALO	15,49	27,25	175,93%	0,00%	US$ 9,07 B	48,21%
REGN	13,35	2,01	15,06%	0,46%	US$ 60,20 B	31,83%
AMGN	29,23	20,54	70,29%	2,47%	US$ 152,60 B	14,67%
VRTX	28,08	5,93	21,11%	0,00%	US$ 101,80 B	31,22%
ADMA	19,62	10,21	52,03%	0,00%	US$ 4,07 B	43,51%
MCK	23,18	-99,57	-429,55%	0,41%	US$ 85,93 B	0,97%
CAH	25,72	-13,51	-52,54%	1,36%	US$ 35,60 B	0,60%
BIIB	11,64	1,17	10,08%	0,00%	US$ 20,68 B	17,46%

comparison of FLXN with indexes

If you had invested (change) 2 years years ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history FLXN dividend history

current DY: 0,57%

5-year average DY: 0,57%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	22/08/2025	25/08/2025	0,14580000

ABOUT THE COMPANY Flexion Therapeutics

Flexion Therapeutics Inc.

Average user rating I10

4.0 (0 people)

Estados Unidos

18 years

Foundation: 2007

2014

Year of debut on the stock exchange - 11 years

257

Employees

The Company Flexion Therapeutics Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 1,26 Billion, having a net worth of $ -82,38 Milhões.

With a total of 257 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 100,40 Milhões, which generated a loss in the amount of $ -100,72 Milhões.

As for its main indicators, the Company has a P/E ratio of -12,47, a P/BV ratio of -15,24 and in the last 12 months the dividend yield of FLXN was at 0,57%.

The Company is traded internationally through the ticker FLXN.

Market value

US$ 1,26 Billion

Net worth

US$ -82,38 Milhões

US$ -82.377.000,00

Assets

US$ 217,93 Milhões

US$ 217.931.000,00

Total Number of Shares

49,40 Milhões

49.403.000

Average Daily Trading Volume

US$ -

Sector

Health Care

Industry

Biotechnology

FLXN

FLXN revenue and profits

FLXN results

DRAG THE FRAME TO SEE MORE DATA

FLXN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 719,80 41,62% (12M)

P/L

23,18

0,41%

ROE

-429,55%

P/VP

-99,57

CAH - Cardinal Health

US$ 152,47 38,27% (12M)

P/L

25,72

1,36%

ROE

-52,54%

P/VP

-13,51

JNJ - Johnson & Johnson

US$ 178,50 11,92% (12M)

P/L

16,71

2,83%

ROE

32,50%

P/VP

5,43

MRK - Merck & Co.

US$ 85,15 --22,88% (12M)

P/L

11,91

3,81%

ROE

36,03%

P/VP

4,29

ABBV - AbbVie

US$ 220,22 17,56% (12M)

P/L

100,08

3,04%

ROE

-2.726,81%

P/VP

-2.728,87

PFE - Pfizer

US$ 24,86 --9,07% (12M)

P/L

15,38

6,87%

ROE

10,33%

P/VP

1,59

AZN - AstraZeneca

US$ 81,10 4,90% (12M)

P/L

27,19

2,53%

ROE

20,79%

P/VP

5,65

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 719,80 41,62% (12 M)

P/L

23,18

0,41%

ROE

-429,55%

P/VP

-99,57

CAH - Cardinal Health

US$ 152,47 38,27% (12 M)

P/L

25,72

1,36%

ROE

-52,54%

P/VP

-13,51

JNJ - Johnson & Johnson

US$ 178,50 11,92% (12 M)

P/L

16,71

2,83%

ROE

32,50%

P/VP

5,43

MRK - Merck & Co.

US$ 85,15 --22,88% (12 M)

P/L

11,91

3,81%

ROE

36,03%

P/VP

4,29

ABBV - AbbVie

US$ 220,22 17,56% (12 M)

P/L

100,08

3,04%

ROE

-2.726,81%

P/VP

-2.728,87

PFE - Pfizer

US$ 24,86 --9,07% (12 M)

P/L

15,38

6,87%

ROE

10,33%

P/VP

1,59

AZN - AstraZeneca

US$ 81,10 4,90% (12 M)

P/L

27,19

2,53%

ROE

20,79%

P/VP

5,65

Common Questions

What is the price of Flexion Therapeutics (FLXN) today?

The price of Flexion Therapeutics (FLXN) today is R$ 137,00, with a variation of 0% compared to the last year. The price of Flexion Therapeutics (FLXN) started the year trading around R$ 0,00 and today it is at R$ 137,00. Follow the real-time price chart, the historical price of Flexion Therapeutics (FLXN), and stock data from Ibovespa and international markets.

When does Flexion Therapeutics (FLXN) pay dividends?

Flexion Therapeutics (FLXN) did not distribute dividends in the last year.

Flexion Therapeutics (FLXN) is it worth it?

Currently, Flexion Therapeutics (FLXN) is priced at R$ 137,00, with a P/E of -12,47%, representing a deviation of -12,47% from its historical average P/E. In the last year, the stock showed a variation of 0% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,57%. The total shareholder return was 0,00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Flexion Therapeutics (FLXN)?

Investing in stocks of Flexion Therapeutics (FLXN) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Flexion Therapeutics (FLXN) yield today?

The yield of Flexion Therapeutics (FLXN) was 1,70% in the last month, 0,00% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,78 in dividends, um Dividend Yield de 0,57%.

If you wanted to buy 100 stocks of Flexion Therapeutics (FLXN) today, the total investment would be R$ 13.700,11, based on the current price of R$ 137,00.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 13.700,11
In 5 years: R$ 13.700,11
In 10 years: 13.700,11

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

FLXN

Flexion Therapeutics Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of FLXN

check out the fundamentals of Flexion Therapeutics shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years years ago, today you would have

current DY: 0,57%

5-year average DY: 0,57%

type

date with

payment date

value

ABOUT THE COMPANY Flexion Therapeutics

Flexion Therapeutics Inc.

Estados Unidos

18 years

2014

257

FLXN results

FLXN cash flow

evolution of assets - FLXN

FLXN balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80